Infectious mononucleosis: medication and diet
Due to the etiology of the disease with the virus, antibiotic treatment is not effective. In the case of treatment of infectious mononucleosis, symptomatic therapy (treatment of symptoms and manifestations) is the primary treatment.
Rest, limitation of excessive physical activity, a diet without a burden on the liver and a sufficient drinking regime are prescribed. Pharmacotherapy (analgesics, antipyretics) is used to reduce painful manifestations and high temperatures.
The actual course of treatment always depends on the severity of the symptoms.
In most cases, visits (check-ups) to the doctor in conjunction with home treatment are sufficient. However, if the disease has a serious course, hospitalization of the patient in the infectious disease ward of a hospital is necessary.
These are mainly cases where there are problems with breathing, swallowing, intense abdominal pain or prolonged high fevers.
As part of the liver diet, it is necessary to limit alcohol, excessive intake of simple sugar and salt, fried and fatty foods. The basis of a healthy lifestyle is the intake of foods rich in nutrients, minerals, vitamins and proteins.
As a prevention of dehydration, a drinking regime in the form of pure water and unsweetened teas is necessary. Drinking herbal teas to regenerate the liver is also supportive, but consultation with a doctor is advisable.
It is recommended to follow the liver diet for at least 3 months.
Lifestyle mainly depends on the success of the treatment and on control blood and liver tests. Changes in blood tests will normalize in approximately 2-3 months.
Symptoms of infectious mononucleosis rarely last longer than 4 months. Most patients with mononucleosis recover from the first unpleasant symptoms within 4 weeks.
However, after cure, the Epstein-Barr virus remains in the human body in its latent hidden form. The immune system has already built up immunity to this type of virus, so reactivation of the virus is rare.
However, if this happens, it is called reactivated mononucleosis.